Scalp biopsy for female hair loss is a minor but diagnostically powerful procedure that allows a dermatologist to examine scalp tissue at a microscopic level, uncovering causes that blood tests and clinical examination alone cannot reliably identify. Female hair loss affects women of all ages and can stem from a wide range of conditions — from common androgenetic alopecia to rarer scarring disorders that require urgent treatment to prevent permanent follicle loss. This article explains when a scalp biopsy is recommended, what the procedure involves on the NHS, how results guide diagnosis, and what treatment options may follow.
Summary: A scalp biopsy for female hair loss is a minor outpatient procedure in which a small core of scalp tissue is removed and examined microscopically to identify the precise cause of hair loss when clinical assessment and blood tests are inconclusive.
- A 4 mm punch biopsy is the most common technique; one or two samples may be taken and processed horizontally or vertically for a complete histological picture.
- Biopsy is especially important when scarring (cicatricial) alopecia is suspected, as early diagnosis can prevent irreversible follicle destruction.
- Histology can distinguish non-scarring conditions (androgenetic alopecia, telogen effluvium, alopecia areata) from scarring conditions (lichen planopilaris, discoid lupus erythematosus, CCCA).
- Direct immunofluorescence (DIF) testing may be requested alongside routine histology when an autoimmune scarring condition such as discoid lupus erythematosus is suspected.
- Results are typically available within two to four weeks and are interpreted alongside clinical findings, blood tests, and medical history.
- Serious complications are uncommon; risks include minor infection, bleeding, small scarring, and rarely localised hair loss at the biopsy site.
Table of Contents
- Why a Scalp Biopsy May Be Recommended for Female Hair Loss
- What to Expect During the Procedure on the NHS
- How Biopsy Results Help Diagnose the Cause of Hair Loss
- Common Conditions Identified Through Scalp Biopsy in Women
- Recovery, Risks, and Aftercare Following the Procedure
- Next Steps and Treatment Options Based on Your Diagnosis
- Frequently Asked Questions
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Why a Scalp Biopsy May Be Recommended for Female Hair Loss
A scalp biopsy is recommended when clinical examination and blood tests fail to provide a definitive diagnosis, particularly if scarring alopecia is suspected or hair loss is progressive and unexplained.
Not sure if this is normal? Chat with one of our pharmacists →
Female hair loss is a complex and often distressing condition that can arise from a wide range of underlying causes. When a clinical examination, blood tests, and patient history fail to provide a definitive diagnosis, a scalp biopsy may be recommended as the next investigative step. This procedure allows a dermatologist to examine the scalp tissue at a microscopic level — the sample is reported by a histopathologist or dermatopathologist — providing information that cannot be obtained through surface-level assessment alone.
A scalp biopsy is particularly useful when hair loss is diffuse, progressive, or does not respond to initial treatments. It is also indicated when there is clinical suspicion of a scarring (cicatricial) alopecia — a group of conditions in which the hair follicle is permanently destroyed by inflammation. Early and accurate diagnosis in these cases is critical, as prompt treatment may help to prevent irreversible follicle loss.
Your GP or dermatologist may refer you for a scalp biopsy if:
-
Hair loss is unexplained after routine blood tests (including thyroid function, ferritin, and full blood count)
-
There are signs of scalp inflammation, scaling, or scarring
-
The pattern of hair loss is atypical or does not fit a straightforward diagnosis
-
Previous treatments have not produced the expected response
If you have features suggesting excess androgen activity — such as irregular periods, acne, or unwanted facial or body hair — your doctor may also arrange androgen tests (including testosterone, sex hormone-binding globulin, and DHEAS) before or alongside a biopsy referral.
Certain features should prompt an urgent dermatology referral rather than a routine one. These include rapidly progressive hair loss, scalp pain or burning, perifollicular redness or scaling, pustules, crusting, or tufting of hairs — all of which may indicate an active scarring alopecia requiring prompt assessment to preserve remaining follicles.
In the UK, referrals for scalp biopsy are made through secondary care dermatology services, either via the NHS or privately. NICE Clinical Knowledge Summaries (CKS) and the Primary Care Dermatology Society (PCDS) support a structured approach to investigating hair loss, ensuring that invasive procedures such as biopsy are used judiciously and only when clinically warranted.
| Condition | Type | Key Histological Features | Follicle Outcome | Additional Tests |
|---|---|---|---|---|
| Androgenetic alopecia (female pattern hair loss) | Non-scarring | Follicular miniaturisation; reduced anagen-to-telogen ratio | Intact; regrowth possible | Androgen bloods (testosterone, SHBG, DHEAS) |
| Telogen effluvium | Non-scarring | Elevated proportion of telogen follicles; no significant inflammation | Intact; regrowth possible | Ferritin, TFTs, FBC |
| Alopecia areata | Non-scarring | Peribulbar lymphocytic infiltrate ('swarm of bees' pattern) | Intact; regrowth possible | Autoimmune screen if indicated |
| Lichen planopilaris / Frontal fibrosing alopecia | Scarring | Lichenoid lymphocytic infiltrate around upper follicle; fibrosis | Permanently destroyed | Clinical correlation; trichoscopy |
| Discoid lupus erythematosus (DLE) | Scarring | Deep inflammatory infiltrate; interface changes; mucin deposition | Permanently destroyed | Direct immunofluorescence (DIF); ANA, dsDNA |
| Central centrifugal cicatricial alopecia (CCCA) | Scarring | Premature desquamation of inner root sheath; perifollicular fibrosis | Permanently destroyed | Clinical correlation; more prevalent in women of African ancestry |
| Folliculitis decalvans | Scarring | Neutrophil-predominant infiltrate; tufting of hairs; pustules | Permanently destroyed | Bacterial swab; different treatment approach from lymphocytic alopecias |
What to Expect During the Procedure on the NHS
A scalp biopsy is performed under local anaesthetic in an outpatient dermatology clinic, takes 15–30 minutes, and involves a 4 mm punch to remove a small core of scalp tissue, closed with one or two sutures.
A scalp biopsy is a minor surgical procedure usually performed in an outpatient dermatology clinic. It is generally quick, well-tolerated, and does not require a general anaesthetic. Understanding what the procedure involves can help to reduce anxiety and ensure you are well prepared.
Before attending, inform the clinic if you are taking any anticoagulant or antiplatelet medicines (such as warfarin, apixaban, rivaroxaban, clopidogrel, or aspirin). Do not stop these medicines without medical advice; the clinical team will advise you on any necessary precautions. If you take warfarin, a recent INR result may be required. Also let the clinic know if you have had any previous reactions to local anaesthetics, dressings, or adhesives.
Before the biopsy, the dermatologist will identify the most appropriate site on the scalp to sample — typically an area of active hair loss rather than completely bald skin, as the latter may yield less diagnostically useful tissue. The scalp is cleaned with an antiseptic solution, and a small amount of local anaesthetic (usually lidocaine, often combined with adrenaline to reduce bleeding) is injected to numb the area. You may feel a brief stinging sensation during this injection, but the biopsy itself should be painless.
The most common technique used is a punch biopsy, in which a small circular blade (typically 4 mm in diameter) is used to remove a cylindrical core of scalp tissue. In some cases, two biopsies may be taken from the same or adjacent sites — one processed horizontally and one vertically — to provide a more complete histological picture. The small wound is usually closed with one or two sutures and covered with a dressing.
The entire procedure typically takes no longer than 15 to 30 minutes. You will be given aftercare instructions before leaving the clinic, and a follow-up appointment will be arranged to discuss results. Suture removal is typically carried out at around 7 to 10 days. On the NHS, waiting times for dermatology appointments can vary by region, so it is worth asking your referring clinician about expected timescales.
How Biopsy Results Help Diagnose the Cause of Hair Loss
Histological analysis reveals follicle density, miniaturisation, anagen-to-telogen ratio, and inflammatory patterns, enabling accurate diagnosis of both scarring and non-scarring alopecias.
Once the scalp tissue sample has been collected, it is sent to a histopathology laboratory where it is processed, stained, and examined under a microscope by a specialist pathologist. This analysis provides detailed information about the structure of the hair follicles, the surrounding tissue, and the presence or absence of inflammation — all of which are essential for reaching an accurate diagnosis.
Histological examination can reveal several key features that guide diagnosis, including:
-
Follicle density and miniaturisation — a reduction in follicle size is characteristic of androgenetic alopecia
-
The ratio of anagen (growing) to telogen (resting) hairs — an elevated telogen count may indicate telogen effluvium
-
The presence, type, and location of inflammatory infiltrate — different patterns of inflammation point to specific scarring or non-scarring conditions
-
Fibrosis or scarring around the follicle — a hallmark of cicatricial alopecias
In cases where an autoimmune or certain scarring condition is suspected — such as discoid lupus erythematosus — the dermatologist may request direct immunofluorescence (DIF) testing on a separate biopsy sample. This technique detects immune deposits in the skin and can provide additional diagnostic information beyond routine histology.
It is worth noting that trichoscopy (dermoscopy of the scalp) is a non-invasive technique that can support clinical assessment and sometimes reduce the need for biopsy; however, it does not replace histological examination when the diagnosis remains uncertain.
The results are interpreted alongside your clinical presentation, blood test findings, and medical history. It is important to understand that histology is not always definitive in isolation; some conditions share overlapping features, and the dermatologist will integrate all available information before confirming a diagnosis.
Results are typically available within two to four weeks. Your dermatologist will discuss the findings with you at a follow-up appointment, explaining what the histological features mean in the context of your individual case. If the results are inconclusive, a repeat biopsy or additional investigations may occasionally be required.
Common Conditions Identified Through Scalp Biopsy in Women
Scalp biopsy distinguishes non-scarring conditions such as androgenetic alopecia and telogen effluvium from scarring alopecias including lichen planopilaris, discoid lupus erythematosus, and CCCA, each requiring different management.
Scalp biopsy is particularly valuable in distinguishing between the many different causes of female hair loss, several of which can appear clinically similar but require very different management approaches.
Non-scarring alopecias — where the follicle remains intact and hair regrowth is potentially possible — include:
-
Androgenetic alopecia (female pattern hair loss): The most common cause of hair loss in women, characterised by follicular miniaturisation and a shift in the anagen-to-telogen ratio
-
Telogen effluvium: A diffuse shedding condition often triggered by physiological stress, nutritional deficiency, or hormonal change, showing an increased proportion of telogen follicles on biopsy
-
Alopecia areata: An autoimmune condition in which a characteristic peribulbar lymphocytic infiltrate ('swarm of bees' pattern) is seen around the follicle bulb
Biopsy can also help to clarify diagnoses that may not be immediately apparent clinically, such as adult tinea capitis (scalp ringworm) or trichotillomania (hair pulling), where histological features can support or confirm the diagnosis when the clinical picture is uncertain.
Scarring (cicatricial) alopecias — where permanent follicle destruction occurs — include:
-
Lichen planopilaris (LPP) and its variant, frontal fibrosing alopecia (FFA): Characterised by a lichenoid lymphocytic infiltrate around the upper follicle
-
Discoid lupus erythematosus (DLE): Shows a deeper inflammatory infiltrate with interface changes and mucin deposition; DIF may be requested to confirm immune deposits
-
Central centrifugal cicatricial alopecia (CCCA): More prevalent in women of African or Afro-Caribbean ancestry, showing premature desquamation of the inner root sheath
-
Folliculitis decalvans: A neutrophilic scarring alopecia characterised by pustules, tufting of hairs, and a neutrophil-predominant infiltrate on biopsy; it requires a different treatment approach from lymphocytic scarring alopecias
Accurate classification of the alopecia type is essential, as scarring conditions require prompt treatment to preserve remaining follicles, whilst non-scarring conditions may be managed more conservatively.
Recovery, Risks, and Aftercare Following the Procedure
Recovery is straightforward; most women resume normal activities immediately, with mild tenderness for one to two days, suture removal at 7–10 days, and a small risk of infection, bleeding, or minor scarring.
Recovery from a scalp biopsy is generally straightforward, and most women are able to return to their normal daily activities immediately after the procedure. The local anaesthetic will wear off within a few hours, and mild tenderness or discomfort at the biopsy site is common for the first day or two. Over-the-counter analgesia such as paracetamol is usually sufficient to manage any post-procedural discomfort.
You will typically be advised to:
-
Keep the biopsy site clean and dry for the first 24 to 48 hours
-
Avoid vigorous exercise or activities that cause excessive sweating in the immediate post-procedural period
-
Refrain from washing your hair until advised it is safe to do so (usually after 24–48 hours)
-
Attend a follow-up appointment for suture removal, usually at around 7 to 10 days
As with any minor surgical procedure, there are small risks associated with scalp biopsy. These include:
-
Infection — signs include increasing redness, warmth, swelling, or discharge from the wound
-
Bleeding or haematoma formation — uncommon but possible, particularly in those taking anticoagulant or antiplatelet medication
-
Scarring — a small scar may remain at the biopsy site, though this is usually concealed by surrounding hair
-
Temporary or, rarely, permanent localised hair loss at the biopsy site
Seek urgent medical attention if:
-
Bleeding does not stop with firm, sustained pressure
-
You develop a fever, rapidly spreading redness around the wound, or feel generally unwell — these may be signs of infection (cellulitis) requiring prompt treatment
Contact your GP or the dermatology department promptly if you have any concerns about wound healing. Serious complications are uncommon, and the diagnostic benefit of the procedure generally outweighs the small procedural risks.
Next Steps and Treatment Options Based on Your Diagnosis
Treatment is tailored to the diagnosis: non-scarring alopecias may be managed with topical minoxidil or off-label oral agents, whilst scarring alopecias require prompt anti-inflammatory treatment — such as hydroxychloroquine or corticosteroids — to halt progression.
Once a diagnosis has been established through scalp biopsy and clinical correlation, your dermatologist will discuss an appropriate management plan tailored to your specific condition. Treatment options vary considerably depending on whether the hair loss is scarring or non-scarring, and whether it is driven by autoimmune, hormonal, nutritional, or inflammatory mechanisms.
For non-scarring alopecias, treatment options may include:
-
Topical minoxidil (available over the counter or on prescription) — a well-established treatment for female pattern hair loss that prolongs the anagen phase and increases follicle size. Important points: it must be used continuously, as hair loss typically returns if treatment is stopped; an initial increase in shedding can occur in the first few weeks and usually settles; potential side effects include scalp irritation, contact dermatitis, and unwanted facial hair (hypertrichosis). Stop use and seek advice if you experience severe irritation.
-
Oral treatments such as spironolactone or finasteride may be considered in certain cases under specialist supervision. Both medicines are used off-label for female hair loss in the UK and are not licensed for this indication. They require specialist oversight, and women of childbearing potential must use effective contraception, as both carry risks in pregnancy. Spironolactone requires baseline and ongoing monitoring of renal function and potassium levels. Finasteride is contraindicated in pregnancy; pregnant women or those who may become pregnant should not handle crushed or broken tablets. Your specialist will discuss the risks and benefits with you before prescribing.
-
Nutritional supplementation where deficiencies (such as iron or vitamin D) have been identified as contributing factors
-
Intralesional corticosteroid injections for alopecia areata, or immunotherapy in more extensive cases, in line with NICE CKS guidance
For scarring alopecias, the primary goal of treatment is to halt disease progression and preserve existing follicles, as regrowth in affected areas is generally not achievable. Treatment may involve:
-
Topical or intralesional corticosteroids to reduce inflammation
-
Hydroxychloroquine for conditions such as LPP, FFA, or DLE. The dose is usually calculated at no more than 5 mg/kg/day based on actual body weight, in line with MHRA and Royal College of Ophthalmologists (RCOphth) guidance. Patients require a baseline ophthalmological risk assessment and ongoing retinal screening — typically from year five of treatment, or earlier if risk factors are present. Your prescriber will arrange this monitoring.
-
Tetracycline antibiotics (such as doxycycline) or other anti-inflammatory agents for conditions such as folliculitis decalvans. Important cautions: take doxycycline with a full glass of water and avoid lying down immediately afterwards; it can cause photosensitivity (use sun protection); it must not be taken during pregnancy or whilst breastfeeding; check for interactions with other medicines.
If you experience any suspected side effects from medicines prescribed for hair loss, you can report these to the Medicines and Healthcare products Regulatory Agency (MHRA) via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. Reporting helps to monitor the safety of medicines in the UK.
Experiencing these side effects? Our pharmacists can help you navigate them →
It is important to maintain regular follow-up with your dermatologist to monitor treatment response and adjust management as needed. If you have concerns about your hair loss at any stage, do not hesitate to contact your GP, who can facilitate onward referral or seek specialist advice on your behalf.
Frequently Asked Questions
Is a scalp biopsy painful for female hair loss diagnosis?
The biopsy itself is painless because local anaesthetic — usually lidocaine with adrenaline — is injected beforehand to numb the area. You may feel a brief sting during the injection, but once the area is numb the procedure causes no pain; mild tenderness at the site for one to two days afterwards is normal and manageable with paracetamol.
How do I get a referral for a scalp biopsy on the NHS?
Your GP can refer you to an NHS dermatology service if your hair loss is unexplained after routine blood tests, shows signs of scarring, or has not responded to initial treatment. Rapidly progressive hair loss, scalp pain, or signs of active inflammation should prompt an urgent rather than routine referral.
Will a scalp biopsy leave a visible scar or bald patch?
A small scar remains at the 4 mm biopsy site, but it is usually concealed by surrounding hair once healed. There is a small risk of temporary or, rarely, permanent localised hair loss at the biopsy site, though this is uncommon and the diagnostic benefit of the procedure generally outweighs this risk.
What is the difference between a scalp biopsy and trichoscopy for diagnosing hair loss?
Trichoscopy (dermoscopy of the scalp) is a non-invasive technique that uses a handheld magnifying device to assess the scalp surface and can support clinical assessment without breaking the skin. A scalp biopsy provides microscopic tissue analysis and remains the gold standard when the diagnosis is uncertain, as it reveals follicle structure, inflammation, and scarring that trichoscopy cannot.
Can I take my regular medicines before a scalp biopsy?
Do not stop any medicines — including blood thinners such as warfarin, apixaban, or clopidogrel — without medical advice before your biopsy. Inform the dermatology clinic of all your current medicines in advance; the clinical team will advise on any necessary precautions, and a recent INR result may be required if you take warfarin.
How long does it take to get scalp biopsy results, and what happens next?
Scalp biopsy results are typically available within two to four weeks, after which your dermatologist will discuss the findings at a follow-up appointment and explain what they mean for your individual case. If results are inconclusive, a repeat biopsy or additional investigations may occasionally be needed before a treatment plan is confirmed.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
